Lab-Grown Salmon Receives FDA Approval In The US, A First For Cultivated Seafood

FDA
California startup clears final regulatory hurdle for cultivated seafood

In a landmark decision for the future of food, the U.S. Food and Drug Administration (FDA) has granted safety approval to lab-grown salmon developed by California-based Wildtype. This marks the first cultivated seafood product to receive FDA clearance and only the fourth lab-grown meat overall to pass pre-market safety consultations.

The company’s coho salmon product—grown from fish cells in bioreactors rather than harvested from oceans—has been deemed as safe as conventional salmon by regulators. Unlike traditional beef and poultry alternatives that require additional USDA approval, Wildtype’s seafood product faces no further regulatory barriers and is already appearing on restaurant menus.

From lab to table: the future of sustainable seafood

Wildtype’s cultivated salmon is currently being served at Kann, an acclaimed Haitian restaurant in Portland, Oregon, with plans to expand to four additional establishments soon. The company began its journey in 2018 with a single stem cell sample from a coho salmon.

“Nobody’s ever written a scientific paper about this,” Wildtype CEO Justin Kolbeck told Technology Networks, describing the challenge of developing the nutrient mix needed to grow fish cells. “There’s no starting point. You just have to do the work and test different combinations.”

The startup positions its product as an environmentally conscious alternative to conventional fishing, citing concerns about overfishing, ocean pollution, and climate change impacts on marine ecosystems. Their process requires no repeated animal slaughter, and research suggests it could spare fish from the prolonged suffering documented in commercial fishing operations.

Challenges ahead for cultivated meat industry

Despite the regulatory milestone, significant hurdles remain:

The approval comes as three other lab-grown meats—two chicken products and one pork alternative—have reached similar FDA milestones. While the chicken products have secured full USDA approval, the pork product awaits final clearance.

“This isn’t about replacing traditional fishing,” a Wildtype spokesperson noted. “It’s about creating sustainable options for a growing population.”

Exit mobile version